New shot shows promise for severe eczema sufferers
Symptom relief
Recruiting now
This study tests an experimental drug called SM17, given as a shot under the skin, for people with moderate-to-severe atopic dermatitis (eczema). About 200 adults aged 18 to 70 will receive either SM17 or a placebo to see if it safely reduces eczema severity and improves symptoms…
Phase: PHASE2 • Sponsor: SinoMab BioScience Ltd • Aim: Symptom relief
Last updated May 11, 2026 20:40 UTC